Peter J Wild

13PUBLICATIONS
83CO-AUTHORS
Cancer geneticsMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 14, 2026
Intratumoral IDH1 mutation status in intrahepatic cholangiocarcinoma is homogeneous.

|Jun 03, 2026
Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.

|Dec 05, 2023
Proteomic-based stratification of intermediate-risk prostate cancer patients.

Qing Zhong, Rui Sun, Adel T Aref

|Oct 28, 2023
Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma.

Bart Vrugt, Michaela B Kirschner, Mayura Meerang

|Oct 14, 2023
Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint®) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v8 T2-T3 Disease.

Mirjana Ziemer, Beate Weidenthaler-Barth, Philipp Gussek

|Sep 09, 2023
Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma.

Katrin Bankov, Falko Schulze, Steffen Gretser

Pageof 3

Frequent Collaborators

3 joint publications

Peter G Hains

3 joint publications

Katrin Bankov

3 joint publications

Qing Zhong

3 joint publications

Maximilian N Kinzler